| Volume: | 1,373,129 |
|---|---|
| Day's Low: | $52.75 |
| 52-wk Low: | $33.34 |
| Previous Close: | $53.29 |
| Dividend: | $1.72 |
| Market Cap: | 120,328,800 |
| Avg Volume: | 1,356,500 |
|---|---|
| Day's High: | $53.23 |
| 52-wk High: | $54.23 |
| Open Price: | $52.78 |
| Yield: | 3.24% |
| P/E (Forward): | 14.64 |
| 1:46 PM | 11/20/2009 | CDC: Sees Slight Decline In H1N1 Influenza Illnesses |
| 1:39 PM | 11/20/2009 | WHO: Mutated H1N1 Virus In Norway Sensitive To Antiviral Drugs |
| 8:34 AM | 11/20/2009 | EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix |
| 4:54 PM | 11/18/2009 | UPDATE: FDA Panel Votes Against Approving Xolair In Children |
| 4:31 PM | 11/18/2009 | FDA Panel Split On Benefits of Genentech's Xolair For Children |
| 12:22 PM | 11/18/2009 | FDA Panel Questions Dosing Levels For Novartis's Xolair |
| 3:41 PM | 11/17/2009 | WSJ CEO COUNCIL: Health Panel Focused On Payment System |
| 11/21/2009 | Shop for Dividends in This Bull Market |
| 11/21/2009 | 10 for the Money |
| 11/20/2009 | Buckle up and take the plunge! |
| 11/19/2009 | The drugmaker slips through an advisory committee unscathed. |
| 11/19/2009 | A move into Japan isn't a bad idea, but it isn't going to save the company either. |
| 11/18/2009 | Pfizer reportedly to sell generic drugs in Japan |
| 11/18/2009 | Be prepared to pay for your own retirement. |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.92 | 0.92 | 0.00 |
| EPS, GAAP | 0.00 | 0.92 | NA |
| Consensus Estimate | 0.95 | 0.99 | -4.04 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | 3.59 | NA |
| EPS, GAAP | 2.43 | 3.33 | -27.03 |
| Consensus Estimate | NA | NA | NA |
| NVS | Industry Average | |
| P/E (TTM) | 21.86 | 16.90 |
| P/E (Forward) | 14.64 | 1.10 |
| PEG Ratio | 7.75 | 0.07 |
| Price/Sales | 3.91 | 3.05 |
| Beta | 0.53 | 0.56 |